I thought this might be of interest to some of the MDC readership:
On February 25, 2014, from 8 a.m. to 5:30 p.m. and on February 26, 2014, from 8 a.m. to approximately 11:15 a.m., the committee will discuss oocyte modification in assisted reproduction for the prevention of transmission of mitochondrial disease or treatment of infertility. On February 26, 2014, from approximately 11:15 a.m. to 11:30 a.m., the committee will hear updates on guidance documents issued from the Office of Cellular, Tissue, and Gene Therapies, Center for Biologics Evaluation and Research (CBER), FDA. On February 26, 2014, from 1 p.m. to approximately 5 p.m., the committee will discuss considerations for the design of early-phase clinical trials of cellular and gene therapy products.
Written submissions may be made to the contact person on or before February 18, 2014.
|19 members and 9,417 guests|
|BeverlyMatthews , davidbeck , incorrigible , jamesmorrow , joandsarah77 , katelove , Katherine73 , Lacontesc04 , lisak1234 , manyhatsmom , mckittre , moominmamma , philomom , Silversky , sren , stephaniepifer , transylvania_mom , zebra15|
|Most users ever online was 449,755, 06-25-2014 at 01:21 PM.|